Clinical trial
Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or…
NCT00109824 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00109824 |
|---|---|
| Title | Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma |
| Official title | A Phase I Study of Decitabine in Combination With Valproic Acid in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma |
| Intervention type | Drug, Other |
| Interventions | decitabine, valproic acid, pharmacological study, laboratory biomarker analysis |
| Enrollment | 42 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2009 |
| First posted | May 4, 2005 |
| Last update posted | Jun 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: